Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
© 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved..
Introduction: Frontline health care workers (HCW) have higher risk than the general population to become infected by SARS.CoV.2, so they were a priority group for Covid-19 vaccine administration. We compared the incidence and prevalence of HCW infected pre-and post-vaccination with the BNT162b2 mRNA COVID-19 vaccine.
Material and methods: Prospective observational study carried out between 01/12/20 and 07/03/21 in La Paz University Hospital, Madrid (Spain). SARS.CoV.2 positive cases in HCW after vaccination were collected and compared to those hospitalized COVID-19 patients at the same hospital.
Results: Two weeks after finishing the first round of vaccinations daily new cases of HCW infections (symptomatic and asymptomatic) decreased substantially and cumulative cases of infected HCW and hospitalized COVID-19 patients started to diverge. No new positive cases of HCW infection were registered seven days after the second dose of BNT162b2 mRNA COVID-19 vaccine.
Conclusions: BNT162b2 mRNA COVID-19 vaccine is highly effective in Spanish HCW.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Enfermedades infecciosas y microbiologia clinica - 41(2023), 1 vom: 01. Jan., Seite 33-35 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Núñez López, Concepción [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 11.01.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.eimc.2021.06.021 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328794031 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328794031 | ||
| 003 | DE-627 | ||
| 005 | 20231225203713.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eimc.2021.06.021 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1095.xml |
| 035 | |a (DE-627)NLM328794031 | ||
| 035 | |a (NLM)34334860 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Núñez López, Concepción |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a Introduction: Frontline health care workers (HCW) have higher risk than the general population to become infected by SARS.CoV.2, so they were a priority group for Covid-19 vaccine administration. We compared the incidence and prevalence of HCW infected pre-and post-vaccination with the BNT162b2 mRNA COVID-19 vaccine | ||
| 520 | |a Material and methods: Prospective observational study carried out between 01/12/20 and 07/03/21 in La Paz University Hospital, Madrid (Spain). SARS.CoV.2 positive cases in HCW after vaccination were collected and compared to those hospitalized COVID-19 patients at the same hospital | ||
| 520 | |a Results: Two weeks after finishing the first round of vaccinations daily new cases of HCW infections (symptomatic and asymptomatic) decreased substantially and cumulative cases of infected HCW and hospitalized COVID-19 patients started to diverge. No new positive cases of HCW infection were registered seven days after the second dose of BNT162b2 mRNA COVID-19 vaccine | ||
| 520 | |a Conclusions: BNT162b2 mRNA COVID-19 vaccine is highly effective in Spanish HCW | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID | |
| 650 | 4 | |a Healthcare workers | |
| 650 | 4 | |a SARS-COV2 | |
| 650 | 4 | |a Vaccine | |
| 700 | 1 | |a González de Abreu, Juan Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Blanco, Verónica |e verfasserin |4 aut | |
| 700 | 1 | |a de Miguel Buckley, Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Romero Gómez, María Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Díaz-Menéndez, Marta |e verfasserin |4 aut | |
| 700 | 0 | |a La Paz Health Care Workers Vaccination Study Group |e verfasserin |4 aut | |
| 700 | 0 | |a Appendix. La Paz Health Care Workers Vaccination Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Enfermedades infecciosas y microbiologia clinica |d 1993 |g 41(2023), 1 vom: 01. Jan., Seite 33-35 |w (DE-627)NLM01273425X |x 1578-1852 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2023 |g number:1 |g day:01 |g month:01 |g pages:33-35 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eimc.2021.06.021 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2023 |e 1 |b 01 |c 01 |h 33-35 | ||